Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency

Detalles Bibliográficos
Autores principales: Farkas, Henriette, Varga, Lilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2012
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873081/
https://www.ncbi.nlm.nih.gov/pubmed/27520465
http://dx.doi.org/10.1007/s13554-012-0004-3
_version_ 1782297057016414208
author Farkas, Henriette
Varga, Lilian
author_facet Farkas, Henriette
Varga, Lilian
author_sort Farkas, Henriette
collection PubMed
description
format Online
Article
Text
id pubmed-3873081
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer Healthcare Communications
record_format MEDLINE/PubMed
spelling pubmed-38730812014-01-02 Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency Farkas, Henriette Varga, Lilian Biol Ther Erratum Springer Healthcare Communications 2012-06-08 /pmc/articles/PMC3873081/ /pubmed/27520465 http://dx.doi.org/10.1007/s13554-012-0004-3 Text en © The Author(s) 2012
spellingShingle Erratum
Farkas, Henriette
Varga, Lilian
Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
title Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
title_full Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
title_fullStr Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
title_full_unstemmed Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
title_short Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
title_sort erratum to: human plasma-derived, nanofiltered c1-inhibitor concentrate (cinryze®), a novel therapeutic alternative for the management of hereditary angioedema resulting from c1-inhibitor deficiency
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873081/
https://www.ncbi.nlm.nih.gov/pubmed/27520465
http://dx.doi.org/10.1007/s13554-012-0004-3
work_keys_str_mv AT farkashenriette erratumtohumanplasmaderivednanofilteredc1inhibitorconcentratecinryzeanoveltherapeuticalternativeforthemanagementofhereditaryangioedemaresultingfromc1inhibitordeficiency
AT vargalilian erratumtohumanplasmaderivednanofilteredc1inhibitorconcentratecinryzeanoveltherapeuticalternativeforthemanagementofhereditaryangioedemaresultingfromc1inhibitordeficiency

Ejemplares similares